#1 Clinical Trials Search in Europe

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

  • Study on the Safety of MB-CART19.1 for Patients with Active Systemic Lupus Erythematosus, Systemic Sclerosis, or Dermatomyositis/Polymyositis

    Recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany

  • Study on the Safety and Effectiveness of CABA-201, Fludarabine Phosphate, and Cyclophosphamide in Patients with Active Systemic Lupus Erythematosus

    Recruiting

    2 1 1 1
    Investigated Drugs:
    France Spain

  • Study on Long-Term Safety of Cenerimod for Adults with Moderate-to-Severe Systemic Lupus Erythematosus

    Recruiting

    3 1 1
    Investigated Drugs:
    Bulgaria Czechia France Germany Greece Poland +3

  • Study on the Effects of Rapcabtagene Autoleucel in Patients with Systemic Lupus Erythematosus and Active, Refractory Lupus Nephritis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Czechia Denmark France Germany Hungary +7

  • Study on Steroid Withdrawal in Systemic Lupus Erythematosus Patients Using Prednisone

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy

  • Study on Long-Term Safety of Ianalumab for Patients with Systemic Lupus Erythematosus

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Czechia France Germany Hungary Italy +5

  • Study on the Effects of Abacavir and Lamivudine in Patients with Systemic Lupus Erythematosus with Low Disease Activity

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

  • Study of Anifrolumab for Children and Teens with Moderate to Severe Lupus

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Italy Poland Portugal Spain

  • Study on the Effectiveness and Safety of Dapirolizumab Pegol for Patients with Moderate to Severe Systemic Lupus Erythematosus

    Recruiting

    3 1 1
    Investigated Drugs:
    Belgium Denmark France Germany Greece Italy +3

  • Study on the Long-Term Safety of Dapirolizumab Pegol for Patients with Systemic Lupus Erythematosus

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Bulgaria Czechia Denmark France Germany +7